Speaker(s): 

Alexander Chang, MD, MS, Associate Professor, Department of Nephrology, Medicine Institute, Department of Population Health Sciences, Research Institute, Co-Director, Center of Kidney Health Research, Geisinger
 
Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

    1. Describe advantages, disadvantages, opportunities for EHR research
    2. Discuss differences in prevalence and severity of genetic diseases in the general population vs. disease focused cohorts
    3. Identify opportunities for learning health system activities to bridge the gap between new research evidence to clinical adoption and improving clinical care
 
Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christa Martin, PhD, Eric Wright, PharmD, MPH, Adam Buchanan, MS, MPH, CGC, Candice Laubach, MBA, Jenn Nunamaker and Christian Lynch, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Dr. Chang has the following disclosures: Novartis, Boeringer-Ingelheim, Novo Nordisk (research grants) and Medscape (consultant/advisor).

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commercial Support for this Session

None.

Session date: 
10/28/2024 - 5:00pm to 6:00pm EDT
Location: 
MS Teams
PA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation Credit

Please login or register to take this course.